Department of Obstetrics and Gynecology, King George's Medical University, Lucknow, Uttar Pradesh, India.
Int J Womens Health. 2013 Mar 6;5:101-8. doi: 10.2147/IJWH.S40473. Print 2013.
Hypertensive disorders complicating pregnancy seriously endanger the safety of the mother and fetus during pregnancy. Very few studies have explored hypertensive disorders of pregnancy in India, even though this disease has been associated with adverse maternal and perinatal outcomes. This study aimed to analyze the disease pattern and risk factors associated with the disorder and assess the maternal and fetal outcomes in cases of hypertensive disorders of pregnancy.
This case-control study was carried out over 1 year from 2011 to 2012 at the Department of Obstetrics and Gynecology, King George's Medical University, Lucknow, Uttar Pradesh, India. A total of 149 patients were enrolled in the study. As seven were lost to follow-up, analysis was carried out on 142 cases. Patients were further classified according to the National High Blood Pressure Education Program Working Group (2000) as having mild preeclampsia (65 cases), severe preeclampsia (32 cases), or eclampsia (45 cases). Thirty-one healthy pregnant non-hypertensive women were enrolled into the study as controls.
The most common manifestation was edema, seen in 90% of cases. Proteinuria was also relatively common, 26.76% of patients with proteinuria of ≥300 mg/24 hours, 47.88% with proteinuria of ≥2 g/24 hours, and 25.35% with a urinary protein excretion of 3-5 g/24 hours. Central nervous system involvement was observed in 42.2% of cases, elevated bilirubin levels in 47.0%, visual symptoms in 6.4%, vaginal bleeding in 11.3%, and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome was reported in 2.80%. Maternal deaths occurred in 2.8% of cases, all of which were from the eclampsia group. Stillbirths occurred in 16.9% of cases, and overall neonatal death observed in 4.23% of cases.
Women with hypertensive disorders of pregnancy were more prone to adverse maternal and fetal outcomes than normotensive pregnant women, but we observed a decreasing trend in the present study compared with that reported in other studies, which might be due to the increased number of hospital deliveries that occurred in our study.
妊娠合并高血压疾病严重危害孕妇及胎儿的孕期安全。尽管妊娠高血压疾病与不良母婴围生结局相关,但在印度,仅有极少数研究对其进行了探讨。本研究旨在分析妊娠高血压疾病的疾病模式及相关危险因素,并评估其母婴结局。
本病例对照研究于 2011 年至 2012 年在印度北方邦勒克瑙的 King George's 医科大学妇产科进行,共纳入 149 例患者。7 例患者失访,故仅对 142 例患者进行了分析。患者根据美国国家高血压教育项目工作组(2000 年)进一步分为轻度子痫前期(65 例)、重度子痫前期(32 例)和子痫(45 例)。同时纳入 31 例健康的非高血压妊娠孕妇作为对照组。
最常见的表现是水肿,见于 90%的病例。蛋白尿也较为常见,26.76%的患者 24 小时蛋白尿≥300mg,47.88%的患者 24 小时蛋白尿≥2g,25.35%的患者 24 小时蛋白尿排泄量为 3-5g。42.2%的病例出现中枢神经系统受累,47.0%的病例胆红素水平升高,6.4%的病例出现视觉症状,11.3%的病例出现阴道出血,2.80%的病例出现 HELLP(溶血、肝酶升高和血小板计数降低)综合征。2.8%的病例出现产妇死亡,均来自子痫组。死胎发生率为 16.9%,新生儿总死亡率为 4.23%。
与正常妊娠孕妇相比,妊娠合并高血压疾病的孕妇更容易出现不良母婴结局,但与其他研究相比,本研究呈下降趋势,这可能是由于本研究中医院分娩的数量增加所致。